Hundreds of drugs may be suspended in EU after flawed tests

London

THE European Medicines Agency called for a halt to sales of hundreds of medicines that were tested in India, after an inspection of the research site found "substitution and manipulation" of study samples.

The recommendation applies to mostly generic medicines from companies including Novartis AG's Sandoz unit, Teva Pharmaceutical Industries Ltd and Mylan Inc, and smaller Indian companies like Lupin Ltd, according to an EMA statement on Friday. Drugs currently being evaluated using studies from the Semler Research Centre Pvt site in Bangalore shouldn't be authorised until alternate data is provided, the agency said.